Xave-TZ Injection
General Range

Xave-TZ Injection

Suave Healthcare Pvt. Ltd.Sector 20, Panchkula, Punjab

Price on request/100 · MOQ 100 boxes

Xave-TZ Injection by Suave Healthcare Pvt. Ltd. contains Ceftriaxone and Tazobactam, a prescription injectable antibiotic combination intended for selected bacterial infections caused by susceptible microorganisms. Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam helps inhibit certain beta-lactamase enzymes associated with antibiotic resistance. Xave-TZ may be considered for selected respiratory tract, urinary tract, skin, soft tissue, and other bacterial infections when combination therapy is clinically appropriate and supported by bacterial susceptibility findings. The formulation is supplied as a 562.5 mg powder for reconstitution and administration by qualified healthcare professionals. Treatment should follow a registered medical practitioner's prescription, considering infection severity, bacterial susceptibility, individual health conditions, and verified product specifications.

CategoryGeneral Range
Min. Order100 boxes
Supplied bySuave Healthcare Pvt. Ltd.
CertificationWHO-GMP, ISO

Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.

View Company

Specifications

Composition
Ceftriaxone & Tazobactam for Injection
Packaging Type
Glass Vial with Carton Box and Solvent Ampoule
Packaging Size
562.5 mg per vial
Dosage Form
Powder for Injection
Treatment
May be considered for selected bacterial respiratory infections, including pneumonia.
Shelf Life
24 Months
Storage
Store below 30°C, protect from light & moisture
Certification
WHO-GMP, ISO

Company Info

Suave Healthcare Pvt. Ltd.Sector 20, Panchkula, Punjab
View Full Profile

Suave Healthcare Private Limited is an ISO 9001:2008 and WHO-GMP certified pharmaceutical company in India specializing in product manufacturing, global supply, and PCD (Propaganda Cum Distribution) franchise operations.

Company Overview

• Founded / Operational: Established in 1985 (operational since 2002) / incorporated as a private limited company.
• Headquarters / Base: Solan and Parwanoo, Himachal Pradesh, India.
• Leadership: Led by Mr. Krishan Kumar Doda (CEO).
• Certifications: ISO 9001:2008 and WHO-GMP certified manufacturing and quality standards.

Core Offerings & Services

• Product Range: Offers over 500 to 850+ formulations across diverse specialty segments.
• Product Categories: Tablets, capsules, syrups, injections, and specialized lines covering general, cardiac, diabetic, dermatological, and pediatric needs.
• Business Models:
• PCD Pharma Franchises: Provides monopoly-based territorial rights, promotional materials, and marketing support for partners across India.
• Third-Party / Contract Manufacturing: Delivers custom and bulk/hospital pharmaceutical manufacturing solutions.

More General Range